Sintx Technologies (NASDAQ:SINT) Announces Quarterly Earnings Results, Misses Estimates By $0.04 EPS

Sintx Technologies (NASDAQ:SINT) announced its quarterly earnings results on Friday. The company reported ($0.70) earnings per share for the quarter, missing the consensus estimate of ($0.66) by ($0.04), FiscalAI reports. The company had revenue of $0.38 million for the quarter, compared to analysts’ expectations of $0.30 million. Sintx Technologies had a negative net margin of 1,018.08% and a negative return on equity of 242.76%.

Sintx Technologies Stock Down 5.4%

SINT traded down $0.13 during trading on Friday, hitting $2.27. The company’s stock had a trading volume of 30,165 shares, compared to its average volume of 40,487. Sintx Technologies has a twelve month low of $1.99 and a twelve month high of $6.78. The business’s fifty day simple moving average is $2.57 and its 200 day simple moving average is $3.14.

Institutional Trading of Sintx Technologies

A hedge fund recently raised its stake in Sintx Technologies stock. Geode Capital Management LLC lifted its position in Sintx Technologies, Inc. (NASDAQ:SINT) by 53.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,624 shares of the company’s stock after acquiring an additional 9,265 shares during the period. Geode Capital Management LLC owned 0.72% of Sintx Technologies worth $103,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 18.38% of the company’s stock.

Analyst Ratings Changes

SINT has been the subject of several recent research reports. Ascendiant Capital Markets reduced their price target on Sintx Technologies from $16.00 to $12.00 and set a “buy” rating for the company in a research report on Wednesday, April 8th. Weiss Ratings reissued a “sell (e+)” rating on shares of Sintx Technologies in a report on Tuesday, April 21st. Finally, HC Wainwright began coverage on Sintx Technologies in a report on Monday, April 13th. They issued a “buy” rating and a $10.00 price objective on the stock. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $11.00.

About Sintx Technologies

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.